Experimentation-Cancer-affected-by-the-crisisLa journal The Lancet provides that the current global economic crisis affect cancer research, making the fight against cancer will suffer a loss of technical and economic. The magazine launches and begins to have some cuts in European research programs. According to a specialist at Imperial College in the next five to seven years the European health plans to increase by 1% annual expenses while demand for treatments for an aging population will increase by 20%.

This situation seems more suitable for Europe because, unlike in the U.S. the latest measures announced by health reactivated Barack Obama in the coming years with an amount of 787,000 million dollars.

The prospect that European public health systems will grow more than substantial to join what could be the loss of funding for research programs of new drugs and treatments against the disease. The pharmaceutical industry and organizations responsible for the collection and investment of funds in cancer research will also experience the arrival of fewer materials.